BSL-3 in-vivo Drug Validation

An infrastructure to conduct research and pre-cinical studies for novel drugs/antibodies in vivo, including: pathogen growth, infection, sample production, kinetic assay, molecular assays, fisiological and comportamental studies, immunological response characterization, neutralization assay, gene expression, inhibition assay, TOA, mechanism of action, neutralization assay, pre-clinical studies.

Service options:

Experiments Planning, Data Analysis, Sample characterization.

For further information and contacts: https://www.icgeb.org/pandemic-preparedness/